ProteoNic and Genencor Sign Research Agreement
Victor Schut, Proteonic CEO: “The enzyme market is focused on product quality and competitive pricing. Genencor is a leader in this market, and their decision to team with us to improve the cost structure of their production will allow us to prove our leadership in this field. It will also further substantiate our track record in the field of fungal production systems. This partnership will demonstrate the value of combining molecular biology expertise (mRNA optimization) with extensive experience in large-scale production process optimization.”
Other news from the department business & finance
Get the life science industry in your inbox
From now on, don't miss a thing: Our newsletter for biotechnology, pharma and life sciences brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.